Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.74 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.74 |
| ▸ | FAAH | O00519 | 2/20 | 0.64 |
| ▸ | DGKA | P23743 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.56 |
| ▸ | RELA | Q04206 | 1/20 | 0.56 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.51 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.51 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.51 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.51 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.51 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.51 |
| ▸ | CES2 | O00748 | 1/20 | 0.51 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 2/20 | 0.49 |
| ▸ | GMNN | O75496 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27375209 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FAAHDGKANFKB1 | |
| SCHEMBL1938968 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FAAHDGKANFKB1 | |
| SCHEMBL2188332 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FAAHDGKANFKB1 | |
| SCHEMBL270143 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FAAHDGKANFKB1 | |
| SCHEMBL28809531 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FAAHDGKANFKB1 | |
| SCHEMBL1573597 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FAAHDGKANFKB1 | |
| SCHEMBL1615525 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FAAHDGKANFKB1 | |
| SCHEMBL22660218 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FAAHDGKANFKB1 | |
| SCHEMBL21314220 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FAAHDGKANFKB1 | |
| SCHEMBL27375210 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FAAHDGKANFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1339776-B1 | POLYANHYDRIDES | EFRAT BIOPOLYMERS LTD (IL) | 2011-07-13 | — | — | EP | disclosed |
| US-7749539-B2 | Therapy for tumor or bone infections; antitumor agents; anticancer agents; bactericides; antiinflammatory agents; administering by injection | EFRAT BIOPOLYMERS LTD. (IL) | 2010-07-06 | — | — | US | disclosed |
| US-7297347-B2 | Polyanhydrides | EFRAT BIOPOLYMERS LTD (IL) | 2007-11-20 | — | — | US | disclosed |
| US-20040161464-A1 | Polymeric formulations for drug delivery | EFRAT BIOPOLYMERS LTD. | 2004-08-19 | — | — | US | disclosed |
| US-20040057970-A1 | Polyanhydrides | EFRAT BIOPOLYMERS LTD. (IL) | 2004-03-25 | — | — | US | disclosed |
| EP-1339776-A2 | POLYANHYDRIDES | Efrat Biopolymers Ltd. (IL) | 2003-09-03 | — | — | EP | disclosed |
| WO-2002044232-A2 | POLYANHYDRIDES | EFRAT BIOPOLYMERS LTD. (IL) | 2002-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040057970-A1 | Polyanhydrides | PARG, PARN, AHR | FFAR1 1064/4885FFAR4 339/4885FAAH 19/4885 |
| US-20040161464-A1 | Polymeric formulations for drug delivery | SBDS, AR, CD47 | FFAR1 54/4885FFAR4 104/4885FAAH 975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.